WAVEMAN · COMPANY

AVNS · Avanos Medical, Inc.

LIVE

TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475TEAM-2.62% 13F +440META+1.00% 13F +2,694RCG+0.35% CLUSTERUTHR-0.54% 13F +425CRWV+5.68% 13F +694CRM-1.97% 13F +1,019CVNA+1.58% 13F +795TPL-1.11% 13F +444NET-1.96% 13F +711MSTR-1.39% 13F +527DELL+1.50% 13F +1,204CRWD-0.87% 13F +1,383ANET+1.22% 13F +1,324COIN-4.18% 13F +475

← ALL COMPANIES

AVNS

Name: AVANOS MEDICAL, INC. (AVNS) insider trading and ownership data
Creator: WaveMan
License: https://wave-man.com/terms

AVANOS MEDICAL, INC.

MEDICAL DEVICES · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · CIK 0001606498

SEC FILINGS☆ WATCH

INSIDER NET · 180D

open-market buys minus sells, Form 4 codes P and S

INSIDER BUYERS · 180D

CONGRESS BUYERS · 1Y

FUNDS ADDED · QTR

144

13F, latest reported quarter

REVENUE GROWTH

+1.9%

XBRL, annual

NET MARGIN

-10.4%

SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST

INSIDERS

no Form 4 purchases or sales on file

CONGRESS

no member of Congress has reported trading it

FUNDS

144 funds added or opened last quarter

more than 67% of Medical Devices

REVENUE

+1.9% year over year

below 68% of Medical Devices

MARGIN

-10.4% net margin

below 51% of Medical Devices

BUYBACKS

$1.3M repurchased, FY to 2026-03-31

below 87% of Medical Devices

SHORT

no short interest reported

THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET

144 funds added or opened positions in the latest 13F quarter, of 289 holders.

Live price

Daily candles from TradingView, on their licence — no filings are marked on this one

WHY THIS NAME IS ON THE DESK

The complete filing record, in one place.

The record shows 144 funds added last quarter. Every figure is a federal filing, dated the day it became public.

Backtest this pattern Open the screener

Same sector, ranked by filing activity

Sector from the SEC's own SIC classification

TMO PEN ROK BLFS MTD SIBN WRBY ISRG TXG DXCM EW TMDX

Insider transactions

Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

No insider purchases or sales are on record for AVANOS MEDICAL, INC. in the period covered. Source: SEC Form 4 filings, as of 2026-09-06.

INSIDER

FILED

VALUE

Holbrook Kerr

SVP, Chief Commercial Officer

SELL

2025-11-18

305.0

$3.4K

Holbrook Kerr

SVP, Chief Commercial Officer

SELL

2025-11-18

100.0

$1.1K

Holbrook Kerr

SVP, Chief Commercial Officer

SELL

2025-11-18

13,834.0

$152.2K

Holbrook Kerr

SVP, Chief Commercial Officer

SELL

2025-11-18

761.0

$8.4K

BLACKFORD GARY

Director

BUY

2025-08-13

20,000.0

$219.6K

18 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 13 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders

13F · holdings as of the latest quarter funds have reported

BlackRock, Inc.

7,468,794.0 sh

$185.8M

NEXPOINT ASSET MANAGEMENT, L.P.

2,177,366.0 sh

$54.2M

STATE STREET CORP

2,010,691.0 sh

$50.0M

VANGUARD CAPITAL MANAGEMENT LLC

1,993,794.0 sh

$49.6M

TIG Advisors, LLC

1,668,329.0 sh

$41.5M

SCHEDULE 13D/G

No 5%+ ownership filings

Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.

FORM 144

No planned-sale notices

No insider has notified an intent to sell. This is the panel to watch after a run-up.

Fund concentration

N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show

DIAMOND HILL SMALL CAP FUND

$5.1M POSITION · AS OF 2026-03-31

2.2%

Thrivent Small Cap Value ETF

$2.8M POSITION · AS OF 2026-03-31

1.8%

Brown Advisory Small-Cap Fundamental Value Fund

$16.8M POSITION · AS OF 2026-03-31

1.6%

Thrivent Small-Mid Cap Equity ETF

$13.3M POSITION · AS OF 2026-03-31

1.5%

Fidelity SAI Merger Arbitrage Fund

$7.3M POSITION · AS OF 2026-04-30

1.3%

State Street(R) SPDR(R) S&P(R) Health Care Equipment ETF

$1.6M POSITION · AS OF 2026-03-31

1.2%

SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK

Executive pay vs shareholder return · Joseph F. Woody

DEF 14A pay-versus-performance disclosure · both the headline pay and the SEC's mark-to-market figure, beside the return the company delivered and the return of the peer group it chose itself

CEO TOTAL

ACTUALLY PAID

OTHER NEOs AVG

TSR

PEER TSR

2023

$7.2M

$4.0M

$2.0M

-33%

+44%

2022

$6.9M

$3.0M

$1.7M

-20%

+39%

2021

$5.5M

$411.4K

$1.3M

+3%

+48%

2020

$7.6M

$11.2M

$1.6M

+36%

+16%

TAGGED BY THE COMPANY UNDER SEC ITEM 402(v) · RETURN IS CUMULATIVE FROM THE START OF THE DISCLOSURE PERIOD · GREEN WHERE THE COMPANY BEAT ITS OWN PEER GROUP

Fundamentals

Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all

	2025-12	2024-12	2023-12	2022-12
REVENUE	$701.2M	$687.8M	$673.3M	$684.1M
GROSS PROFIT	$353.9M	$381.3M	$379.7M	$394.2M
OPERATING INCOME	$-61.6M	$-396.2M	$4.2M	$35.5M
NET INCOME	$-72.9M	$-392.1M	$-61.8M	$50.5M
EPS (DILUTED)	-1.57	-8.53	-1.32	1.07
OPERATING CASH FLOW	$74.7M	$100.7M	$32.4M	$90.9M
CASH	$89.8M	$107.7M	$87.7M	$127.7M
LONG-TERM DEBT	$90.3M	$125.3M	$159.4M	$226.3M
BUYBACKS	$3.3M	$12.8M	$19.1M	$45.5M

SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-06 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE